Machine Learning Methods and Docking for Predicting Human Pregnane X Receptor Activation
Akash Khandelwal(Merck KGaA, Darmstadt (Germany)), Sean Ekins(Collaborative Drug Discovery (United States)), Erica J. Reschly(University of Pittsburgh), Peter W. Swaan(University of Maryland, Baltimore), Matthew D. Krasowski(University of Iowa), Michael Sinz(Rutgers, The State University of New Jersey)
Cited by 71
Related Papers
<i>In silico</i> pharmacology for drug discovery: methods for virtual ligand screening and profiling
|British Journal of Pharmacology|2007|693
CYP3A4 Induction by Drugs: Correlation between a Pregnane X Receptor Reporter Gene Assay and CYP3A4 Expression in Human Hepatocytes
|Drug Metabolism and Disposition|2002|447
Inactivation of Cytochrome P450 3A4 by Bergamottin, a Component of Grapefruit Juice
|Chemical Research in Toxicology|1998|312
Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole
|Oncogene|2006|211
Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032)
|Antimicrobial Agents and Chemotherapy|2012|186